BSCL2 and liver disorder: Given that FGF21 dysregulation has been described in lipodystrophic patients and in seipin-deficient mice [17,18,19], we aimed to characterize the hepatic FGF21 pathway in our models to better understand its potential role in the pathogenesis of seipin-related liver disease.